PuSH - Publication Server of Helmholtz Zentrum München: Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Reiner, A.P.* ; Hartiala, J.* ; Zeller, T.* ; Bis, J.C.* ; Dupuis, J.* ; Fornage, M.* ; Baumert, J.J. ; Kleber, M.E.* ; Wild, P.S.* ; Baldus, S.* ; Bielinski, S.J.* ; Fontes, J.D.* ; Illig, T. ; Keating, B.J.* ; Lange, L.A.* ; Ojeda, F.* ; Müller-Nurasyid, M. ; Munzel, T.F.* ; Psaty, B.M.* ; Rice, K.* ; Rotter, J.I.* ; Schnabel, R.B.* ; Tang, W.H.* ; Thorand, B. ; Erdmann, J.* ; CARDIoGRAM Consortium (Wichmann, H.-E. ; Illig, T. ; Klopp, N. ; Meitinger, T. ; Peters, A. ; Meisinger, C. ; Döring, A.) ; Jacobs, D.R.* ; Wilson, J.G.* ; Koenig, W.* ; Tracy, R.P.* ; Blankenberg, S.* ; Marz, W.* ; Gross, M.D.* ; Benjamin, E.J.* ; Hazen, S.L.* ; Allayee, H.*

Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.

Hum. Mol. Genet. 22, 3381-3393 (2013)

Publ. Version/Full Text Volltext

DOI

PMC

	Closed

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Increased systemic levels of myeloperoxidase (MPO) are associated with the risk of coronary artery disease (CAD). To identify the genetic factors that are associated with circulating MPO levels, we carried out a genome-wide association study (GWAS) and a gene-centric analysis in subjects of European ancestry and African Americans (AAs). A locus on chromosome 1q31.1 containing the complement factor H (CFH) gene was strongly associated with serum MPO levels in 9305 subjects of European ancestry (lead SNP rs800292; P = 4.89 × 10(-41)) and in 1690 AA subjects (rs505102; P = 1.05 × 10(-8)). Gene-centric analyses in 8335 subjects of European ancestry additionally identified two rare MPO coding sequence variants that were associated with serum MPO levels (rs28730837, P = 5.21 × 10(-12); rs35897051, P = 3.32 × 10(-8)). A GWAS for plasma MPO levels in 9260 European ancestry subjects identified a chromosome 17q22 region near MPO that was significantly associated (lead SNP rs6503905; P = 2.94 × 10(-12)), but the CFH locus did not exhibit evidence of association with plasma MPO levels. Functional analyses revealed that rs800292 was associated with levels of complement proteins in serum. Variants at chromosome 17q22 also had pleiotropic cis effects on gene expression. In a case-control analysis of ∼80 000 subjects from CARDIoGRAM, none of the identified single-nucleotide polymorphisms (SNPs) were associated with CAD. These results suggest that distinct genetic factors regulate serum and plasma MPO levels, which may have relevance for various acute and chronic inflammatory disorders. The clinical implications for CAD and a better understanding of the functional basis for the association of CFH and MPO variants with circulating MPO levels require further study.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

7.692

1.762